HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
David M Jablons Selected Research
David M Jablons Research Topics
Disease
81
Neoplasms (Cancer)
12/2021 - 01/2003
31
Lung Neoplasms (Lung Cancer)
05/2021 - 01/2003
26
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2021 - 07/2002
25
Mesothelioma
02/2020 - 07/2002
17
Malignant Mesothelioma
01/2021 - 07/2002
16
Carcinogenesis
05/2020 - 08/2003
15
Neoplasm Metastasis (Metastasis)
05/2020 - 05/2005
6
Adenocarcinoma of Lung
12/2021 - 03/2006
5
Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar)
01/2013 - 03/2006
3
Sarcoma (Soft Tissue Sarcoma)
01/2019 - 05/2005
3
Adenocarcinoma
01/2016 - 01/2012
3
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2015 - 01/2012
2
Carcinoid Tumor (Carcinoid)
09/2016 - 08/2014
2
Genomic Instability
05/2015 - 06/2014
2
Colorectal Neoplasms (Colorectal Cancer)
09/2007 - 04/2005
2
Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
03/2007 - 12/2005
2
Malignant Pleural Effusion
03/2005 - 08/2003
1
COVID-19
06/2021
1
Infections
06/2021
1
Wounds and Injuries (Trauma)
01/2021
1
Breast Neoplasms (Breast Cancer)
09/2019
1
Noninfiltrating Intraductal Carcinoma (DCIS)
09/2019
1
Coronary Artery Disease (Coronary Atherosclerosis)
09/2019
1
Non-ST Elevated Myocardial Infarction
09/2019
1
Pathologic Complete Response
01/2019
Drug/Important Bio-Agent (IBA)
26
Proteins (Proteins, Gene)
FDA Link
05/2020 - 07/2002
16
Small Interfering RNA (siRNA)
IBA
01/2019 - 01/2004
12
Biomarkers (Surrogate Marker)
IBA
06/2021 - 01/2008
11
beta Catenin
IBA
09/2007 - 08/2003
6
Cullin Proteins (Cullins)
IBA
01/2021 - 02/2011
6
Pharmaceutical Preparations
IBA
06/2017 - 01/2008
6
Ligands
IBA
07/2013 - 01/2004
5
Casein Kinase II (Casein Kinase 2)
IBA
11/2013 - 05/2009
4
Antibodies
IBA
06/2021 - 04/2003
4
DNA (Deoxyribonucleic Acid)
IBA
01/2020 - 05/2003
3
Protein Isoforms (Isoforms)
IBA
05/2021 - 08/2005
3
ErbB Receptors (EGF Receptor)
IBA
08/2019 - 07/2007
3
B7-H1 Antigen
IBA
08/2019 - 12/2017
3
Gemcitabine
FDA Link
01/2016 - 11/2008
3
Messenger RNA (mRNA)
IBA
11/2014 - 01/2012
3
Carboplatin (JM8)
FDA Link
Generic
10/2013 - 06/2004
3
Survivin
IBA
10/2008 - 07/2002
3
Secreted Frizzled-Related Proteins
IBA
09/2007 - 08/2004
3
Monoclonal Antibodies
IBA
05/2005 - 01/2004
3
WD repeat containing planar cell polarity effector
IBA
04/2005 - 08/2004
2
Sulfatases
IBA
05/2021 - 01/2012
2
Phosphotransferases (Kinase)
IBA
02/2021 - 08/2003
2
Paclitaxel (Taxol)
FDA Link
Generic
01/2021 - 06/2004
2
Verteporfin (Visudyne)
FDA Link
01/2017 - 08/2016
2
Adenosine Triphosphate (ATP)
IBA
01/2017 - 07/2013
2
Formaldehyde (Formol)
FDA Link
01/2017 - 07/2016
2
Paraffin
IBA
01/2017 - 07/2016
2
Erlotinib Hydrochloride (CP 358,774)
FDA Link
08/2016 - 01/2009
2
Transforming Growth Factors (Transforming Growth Factor)
IBA
01/2016 - 12/2015
2
Biological Products
IBA
07/2015 - 08/2003
2
Cisplatin (Platino)
FDA Link
Generic
06/2014 - 11/2007
2
hematein
IBA
11/2013 - 05/2009
2
Docetaxel (Taxotere)
FDA Link
10/2013 - 04/2005
2
Platinum
IBA
11/2011 - 04/2010
2
Gefitinib (Iressa)
FDA Link
01/2009 - 07/2006
2
Tyrosine Kinase Inhibitors
IBA
01/2009 - 07/2007
2
2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- one
IBA
11/2008 - 12/2005
2
Sirolimus (Rapamycin)
FDA Link
11/2008 - 12/2005
2
Glycoproteins (Glycoprotein)
IBA
01/2006 - 08/2005
1
RNA (Ribonucleic Acid)
IBA
12/2021
1
Tetraspanins
IBA
06/2021
1
ponatinib
IBA
01/2021
1
Growth Factor Receptors
IBA
05/2020
1
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
05/2020
1
Cyclin-Dependent Kinases (cdk Proteins)
IBA
01/2020
1
Antineoplastic Agents (Antineoplastics)
IBA
01/2020
1
Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)
IBA
01/2020
1
Estrogen Receptors
IBA
09/2019
1
Progesterone Receptors (Progesterone Receptor)
IBA
09/2019
1
Immune Checkpoint Inhibitors
IBA
08/2019
1
Dimethyl Sulfoxide (DMSO)
FDA Link
Generic
08/2019
1
cucurbitacin E
IBA
08/2019
1
Triterpenes
IBA
08/2019
1
antineoplaston A10 (A 10)
IBA
05/2019
1
Annexins
IBA
05/2019
1
Tumor Suppressor Proteins (Proteins, Tumor Suppressor)
IBA
05/2019
1
Crizotinib
IBA
01/2019
1
Programmed Cell Death 1 Receptor
IBA
12/2017
1
Membrane Proteins (Integral Membrane Proteins)
IBA
12/2017
Therapy/Procedure
41
Therapeutics
05/2020 - 01/2003
17
Drug Therapy (Chemotherapy)
01/2018 - 12/2002
5
Adjuvant Chemotherapy
12/2021 - 01/2015
5
Radiotherapy
02/2020 - 12/2002
3
Immunotherapy
05/2020 - 01/2018
3
Pneumonectomy (Lung Volume Reduction)
02/2020 - 02/2007
3
Neoadjuvant Therapy
12/2016 - 04/2007
2
Metastasectomy
01/2019 - 04/2014
2
Esophagectomy
12/2016 - 01/2012
2
Precision Medicine
07/2016 - 01/2015
2
Investigational Therapies (Experimental Therapy)
07/2015 - 06/2014
2
Operative Surgical Procedures
04/2014 - 05/2009
2
Chemoradiotherapy
01/2009 - 04/2007
1
Oral Administration
01/2020
1
Coronary Artery Bypass (Coronary Artery Bypass Surgery)
09/2019
1
Segmental Mastectomy (Lumpectomy)
09/2019